RE:RE:Willow and CardiolYou can only specialize in so much, especially as an early biotech co. Willow can have creams and ointments or whatever the F@#k they plan on getting in to. We are going after heart disease with some of the best heart specialists in the world, we also have an oppurtunity to sell high end cbd that we know has a market. See epidiolex and GW Pharma.
The CBD landscape is constantly changing and the street is very unsure of who will come out on top. We are betting on Cardiol being one of the companies that comes out of this as a winner. Cheers Frank